We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Rectangle Image
News

BioFocus Receives Rapid Response Innovation Award from The Michael J. Fox Foundation

Rectangle Image
News

BioFocus Receives Rapid Response Innovation Award from The Michael J. Fox Foundation

Read time:
 

BioFocus has announced that it has received a Rapid Response Innovation Award from The Michael J. Fox Foundation for Parkinson’s Research, a not-for-profit organization focused on developing therapies for Parkinson’s disease.

BioFocus will use the investment to develop a high-throughput, high-content assay platform to support the discovery of targets and agents that break the pathogenic loop between glucocerebrosidase (GBA) and a-synuclein, considered to be a major mechanism leading to Parkinson’s disease.

The project is further supported by a new collaboration between BioFocus and Professor Tony Schapira, Institute of Neurology, University College London, a renowned medical researcher in Parkinson’s disease.

Prof. Tony Schapira commented: “The link between mutations in the GBA gene and Parkinson’s disease has been affirmed by multiple clinical studies. The development of a disease-relevant cell model system to support drug discovery on this mechanism will be a critical asset to the Parkinson’s disease research community.”

Prof. Julie Frearson, Senior Director Scientific Alliances and Translational Research, BioFocus, said: “We are delighted and honored to receive this grant. This funding will allow BioFocus to continue tackling novel and challenging therapeutic mechanisms in Parkinson’s disease.”

Advertisement